NCT02073084View on ClinicalTrials.gov

A Thorough Corrected QT Interval Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Conditions
Dyslipidemia
Interventions
DRUG

K-877 Low Dose

K-877 Low Dose

DRUG

Moxifloxacin

OTHER

Placebo

DRUG

K-877 High Dose

K-877 High Dose

Trial Locations (1)

Unknown

Austin

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY